Clinical Trial Update: Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 study comparing brinzolamide/brimonidine fixed-dose combination given twice daily to its individual components in open-angle glaucoma or ocular hyperten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Brimonidine (brimonidine)
• Brinzolamide (Brinzolamide)
• Brinzolamide/brimonidine fixed-dose combination (Brinzolamide; Brimonidine)

Snippet

Sponsor: Alcon Research | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2014-03-06